Heart Test Laboratories I... (HSCSW)
0.04
-0.01 (-20.00%)
At close: Jan 15, 2025, 11:27 AM
0.04
0.00%
Pre-market Jan 15, 2025, 11:27 AM EST
Company Description
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices.
The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information.
It serves clinics, doctor's offices, urgent care centers, and hospitals.
The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Heart Test Laboratories Inc.
| Country | United States |
| IPO Date | Jun 15, 2022 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Andrew Simpson |
Contact Details
Address: 550 Reserve Street Southlake, Texas United States | |
| Website | https://heartsciences.com |
Stock Details
| Ticker Symbol | HSCSW |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| CIK Code | 0001468492 |
| CUSIP Number | 42254E112 |
| ISIN Number | US42254E1120 |
| Employer ID | 26-1344466 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Andrew Simpson | Chief Executive Officer, President & Chairman of the Board of Directors |
| Danielle Watson | Chief Financial Officer & Treasurer |
| Mark T. Hilz | Chief Operating Officer, Secretary & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 19, 2024 | RW | Filing |
| Dec 17, 2024 | 8-K | Current Report |
| Dec 17, 2024 | RW | Filing |
| Dec 16, 2024 | 8-K | Current Report |
| Dec 16, 2024 | 10-Q | Quarterly Report |
| Nov 08, 2024 | 8-K | Current Report |
| Oct 21, 2024 | 8-K/A | [Amend] Current Report |
| Oct 18, 2024 | 8-K | Current Report |
| Sep 27, 2024 | S-1/A | [Amend] Filing |
| Sep 26, 2024 | DEFA14A | Filing |